Helium
Helium is an odorless, tasteless, nonexplosive, noncombustible, nontoxic and physiologically inert gas and has been used safely in the treatment of respiratory disease since 1979 [26, 27]. It diffuses very rapidly to the target organs because of its low atomic weight. It is also nonreactive with body tissues and relatively insoluble in body fluid. The physical properties of helium such as its low density, laminar flow and low driving pressure decrease airway resistance making it an attractive treatment for respiratory diseases that involve a decrease in airway diameter and consequently increased airway resistance, such as bronchial asthma, chronic obstructive pulmonary disease and bronchiolitis. Patients with these conditions may suffer a range of symptoms including breathlessness, hypoxemia and eventually a weakening of the respiratory muscles, which can lead to respiratory failure requiring intubation and mechanical ventilation. Helium can reduce all these effects, making it easier for the patient to breathe by lowered airway resistance, thereby requiring less mechanical energy to ventilate the lungs. Helium is reported to increase in the coronary collateral circulation and enhance the vasodilator effect of inhaled nitric oxide on pulmonary vessels. The physical properties of helium may result in more efficient uptake oxygen and a facilitation of nitrogen egress from affected mitochondria in transient cerebral ischemia, both of which may explain its beneficial effects.
Ozone
Ozone is a triatomic molecule consisting of three oxygen atoms. Ozone is a pale blue gas with a sharp, cold, irritating odor and is produced naturally by electrical discharges following thunderstorms or ultraviolet (UV) rays emitted from the sun. Ozone is present in low concentrations throughout the Earth’s atmosphere; however, an ozone layer exists between 10 and 50 km above from the surface of the earth and plays a very important role filtering UV rays which is critical for the maintenance of biological balance in the biosphere. Ozone gas has a high oxidation potential and is widely used in treatment of water in aquariums and fish ponds to minimize bacterial growth, control parasites, and eliminate transmission of some diseases. Ozone inhalation (0.1-1 ppm) can be toxic to the pulmonary system and cause upper respiratory irritation, rhinitis, headache, and occasionally nausea and vomiting. However, ozone has been used as a therapeutic agent for the treatment of different diseases by creating resistance against oxidative stress via inducing an antioxidative system. Ozone, administered by rectal insufflation, prior to ischemia/reperfusion injury, prevents the damage induced by ROS and attenuates renal and hepatic ischemia/reperfusion injury [28]. Medical applications of blood ozonation via extracorporeal blood oxygenation and ozonation was found to be safe and effective in treating peripheral artery disease in clinical trials [29, 30].
Conclusions
As highlighted above, the ability of medical gases to ameliorate oxidative stress plays an important role at the chemical, cellular and physiological levels. Although some medical gases may cause serious adverse effects, there are still many possible applications of these gases as therapeutic tools for various diseases if the concentrations are tightly controlled. The future of medical gas therapy must focus on the establishment of safe and well-defined administration parameters and on randomized controlled trials to determine the precise indications and guidelines for the use of medical gases in the treatment of various pathologies.
References
1 Nakao A, Sugimoto R, Billiar TR, et al: Therapeutic antioxidant medical gas. J Clin Biochem Nutr 2009;44:1-13.
2 Motterlini R, Mann BE, Foresti R: Therapeutic applications of carbon monoxide-releasing molecules. Expert Opin Investig Drugs 2005;14:1305-1318.
3 Lundberg JO, Weitzberg E, Gladwin MT: The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov 2008;7:156-167.
4 Kajiya M, Sato K, Silva MJ, et al: Hydrogen from intestinal bacteria is protective for concanavalin A-induced hepatitis. Biochem Biophys Res Commun 2009;386:316-321.
5 Bathoorn E, Slebos DJ, Postma DS, et al: Anti-inflammatory effects of inhaled carbon monoxide in patients with COPD: a pilot study. Eur Respir J 2007;30:1131-1137.
6 Culotta E, Koshland DE Jr: NO news is good news. Science1992; 258:1862-1865.
7 Creagh-Brown BC, Griffiths MJ, Evans TW: Bench-to-bedside review: Inhaled nitric oxide therapy in adults. Crit Care 2009;13:221.
8 Michael JR, Barton RG, Saffle JR, et al: Inhaled nitric oxide versus conventional therapy: effect on oxygenation in ARDS. Am J Respir Crit Care Med 1998;157:1372-1380.
9 Tenhunen R, Marver HS, Schmid R: The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci USA 1968;61:748-755.
10 Pannen BH, Kohler N, Hole B, et al: Protective role of endogenous carbon monoxide in hepatic microcirculatory dysfunction after hemorrhagic shock in rats. J Clin Invest 1998;102:1220-1228.
11 Nakahira K, Kim HP, Geng XH, et al: Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROS-induced trafficking of TLRs to lipid rafts. J Exp Med 2006;203:2377-2389.
12 Kamoun P: Endogenous production of hydrogen sulfide in mammals. Amino Acids 2004;26:243-254.
13 Leslie M: Medicine. Nothing rotten about hydrogen sulfide’s medical promise. Science 2008;320:1155-1157.
14 Blackstone E, Morrison M, Roth MB: H2S induces a suspended animation-like state in mice. Science 2005;308:518.
15 Ohsawa I, Ishikawa M, Takahashi K, et al: Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med 2007; 13:688-694.
16 Hayashida K, Sano M, Ohsawa I, et al: Inhalation of hydrogen gas reduces infarct size in the rat model of myocardial ischemia-reperfusion injury. Biochem Biophys Res Commun 2008;373:30-35.
17 Ohsawa I, Nishimaki K, Yamagata K, et al: Consumption of hydrogen water prevents athero-sclerosis in apolipoprotein E knockout mice. Biochem